Search results (38)
« Back to News & OpinionNews and Opinion from the Pandemic Sciences Institute at the University of Oxford
New paper outlines ethical issues in clinical metagenomics
7 March 2025
This week, University of Oxford researchers published the first paper mapping clinical ethics questions raised by new metagenomic techniques for diagnosing disease in clinical practice.
Advances in AI can help prepare the world for the next pandemic
19 February 2025
- Epidemiology & data
- Ethics, social science & humanities
- Pathogen biology & new threats
- Research news
- Vaccines, treatments, diagnostics & trials
In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.
New partnership to advance public health and life science research collaboration in West Africa
13 February 2025
PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.
Study provides new insights into mpox clinical outcomes and transmission
16 January 2025
Results of MOSAIC, a European observational study led by researchers at PSI and ISARIC, provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission.
Pig research paves way for human respiratory vaccine development
9 January 2025
A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.
University of Oxford unveils new vaccine development partnership
15 November 2024
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.
Study explores aerosol immunisation as path to broadly protective influenza vaccine
16 October 2024
Scientists at PSI and Pirbright have taken a significant step towards developing a universal influenza vaccine.
Oxford Vaccine Group announces return of science and healthcare podcast
19 September 2024
A brand-new season of The Oxford Colloquy – a podcast series of conversations with leading experts in science and healthcare – is launched this week by Oxford Vaccine Group.
PSI collaborates with Oxford’s History of Science Museum on new exhibition
12 August 2024
The latest exhibition "A Healthy Future for All?" explores the science driving advancements in healthcare.
Oxford scientists launch first-in-human vaccine trial for deadly Marburg virus
12 July 2024
Launch of UK trial is major milestone in developing a vaccine against Marburg virus – a highly virulent disease that is fatal in up to 88% of cases.
Pandemic computer simulations to guide future vaccine trials
23 May 2024
PSI scientists are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.
Science Museum’s Injecting Hope exhibition enters final week
2 May 2024
The exhibition, which features stories and items from University of Oxford researchers, explores the worldwide effort to develop vaccines against COVID-19 and shares the inspiring stories of scientists collaborating around the globe to save lives. Closing on 12 May, the exhibition has welcomed millions of visitors in London, India and China.
Researchers enrol record number of patients for landmark plague trial
26 April 2024
A randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.
Oxford hosts Belgian vaccine experts
28 March 2024
Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.
FCDO Minister meets with University of Oxford’s vaccine researchers
26 January 2024
The University of Oxford this week welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.
Vaccine trial for deadly Nipah virus launched
11 January 2024
Oxford-led UK trial is first step to developing a vaccine against Nipah virus – a devastating disease mostly found in South-East Asia.
New partnership aims to advance vaccine against MERS coronavirus
21 December 2023
A partnership between CEPI, Barinthus Biotherapeutics and the University of Oxford aims to fast-track the development of a potential vaccine for the prevention of Middle East Respiratory Syndrome (MERS).
Oxford receives £7.8 million to develop vaccines to fight epidemic and pandemic threats
12 December 2023
New funding will support research into the prevention of five dangerous diseases with epidemic and pandemic potential.
Oxford welcomes global pandemic experts for focus on 100 Days Mission
2 November 2023
Scientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford’s vaccine laboratories as part of a two-day meeting of the global coalition.
CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
2 November 2023
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, with a new project led by Professor Teresa Lambe.